Form 4: Northrop Grumman CFO Granted Equity Awards
Insider Transaction Report
Northrop Grumman's Chief Financial Officer, John Greene, received grants of Restricted Performance Stock Rights and Restricted Stock Rights under the 2024 Long-Term Incentive Stock Plan.
Summary
- John Greene, CVP & Chief Financial Officer of Northrop Grumman Corp, was granted equity awards.
- Received 4,981 Restricted Performance Stock Rights (RPSRs) on February 11, 2026, which vest based on performance metrics over a measurement period ending December 31, 2028.
- Received 5,362 Restricted Stock Rights (RSRs) on February 11, 2026, with various vesting dates: 2,298 RSRs vesting on February 12, 2029; 1,532 RSRs vesting on February 11, 2027; and 1,532 RSRs vesting on February 11, 2028.
- Both grants were made under the 2024 Long-Term Incentive Stock Plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive, routine disclosure reflecting standard executive compensation practices designed to align management incentives with long-term company performance.
Positives
- Grants align management incentives with long-term company performance and shareholder value.
- The awards are part of a standard long-term incentive plan, indicating ongoing commitment to executive compensation strategies.
Future Outlook
The filing details future vesting schedules for equity awards granted to the Chief Financial Officer, with RPSRs vesting based on performance through December 31, 2028, and RSRs vesting on various dates up to February 12, 2029.
Industry Context
StockSavvy.ai notes that granting long-term equity incentives to key executives like the CFO is a standard practice in the defense and aerospace industry, aligning executive interests with long-term shareholder value creation. This is consistent with compensation strategies observed across major defense contractors.
Comparison to Industry Standards
- Granting performance-based and time-based restricted stock units to senior executives is a common compensation strategy among large-cap defense contractors such as Lockheed Martin (LMT), Raytheon Technologies (RTX), and Boeing (BA).
- These plans typically aim to incentivize long-term performance and retention, with vesting schedules often spanning three to five years, similar to the awards detailed for Northrop Grumman's CFO.
Stakeholder Impact
- Shareholders: Potential for increased alignment of executive interests with long-term shareholder value through performance-based incentives.
- Employees: No direct impact on general employees, but reflects the company's executive compensation structure.
Next Steps
- Vesting of 1,532 RSRs on February 11, 2027.
- Vesting of 1,532 RSRs on February 11, 2028.
- Measurement period for RPSRs ends on December 31, 2028, followed by potential vesting.
- Vesting of 2,298 RSRs on February 12, 2029.
Key Dates
| Date | Description |
|---|---|
| 02/11/2026 | Date of grant for Restricted Performance Stock Rights and Restricted Stock Rights. |
| 02/13/2026 | Date the Form 4 was signed by Attorney-in-Fact. |
| 02/11/2027 | Vesting date for 1,532 Restricted Stock Rights. |
| 02/11/2028 | Vesting date for 1,532 Restricted Stock Rights. |
| 12/31/2028 | End of measurement period for Restricted Performance Stock Rights. |
| 02/12/2029 | Vesting date for 2,298 Restricted Stock Rights. |
Recommendation
holdThis Form 4 filing details routine equity grants to a key executive, which is a standard practice for executive compensation and incentive alignment. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a catalyst for significant upward or downward re-evaluation of the stock.
Keywords
Northrop Grumman, NOC, Form 4, Insider Transaction, Equity Grant, Restricted Stock, Performance Stock, Executive Compensation, John Greene, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.